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Effects of triethylene glycol 
dimethacrylate (TEGDMA) on the 
odontoclastic differentiation ability of 
human dental pulp cells
Objectives: The primary purpose of this study was to examine the 
effects of triethylene glycol dimethacrylate (TEGDMA) on odontoclastic 
differentiation in the dental pulp tissue. Material and Methods: The effects of 
different TEGDMA dosages on the odontoclastic differentiation capability of 
dental pulp cells were analyzed in vitro using the following methodologies: 
??????????????????????????????????????????????????????????????????????????
ii) apoptotic effects using Annexin V staining; iii) mRNA expression of 
osteoprotegerin (OPG) and receptor activator of nuclear factor (NF)-kB 
ligand (RANKL) genes by quantitative Real-time PCR (qRT-PCR); and iv) 
OPG and RANKL protein expression by enzyme-linked immunosorbent assay 
(ELISA). Results: TEGDMA caused relatively less odontoclastic differentiation 
in comparison with the control group; however, odontoclastic differentiation 
augmented with increasing doses of TEGDMA (p<0.05). The mRNA and 
protein expression of OPG was lower in TEGDMA treated pulp cells than in 
the control group (p<0.05). While the mRNA expression of RANKL remained 
unchanged compared to the control group (p>0.05), its protein expression 
was higher than the control group (p<0.05). In addition, TEGDMA increased 
the apoptosis of dental pulp cells dose dependently. Conclusions: TEGDMA 
reduced the odontoclastic differentiation ability of human dental pulp cells. 
However, odontoclastic differentiation ratios increased proportionally with 
the increasing dose of TEGDMA.
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Introduction
Triethylene glycol dimethacrylate (TEGDMA) is 
a resin monomer widely used in the composition 
of dentin bonding agents and composite resins to 
restore teeth structures impaired by caries and/or 
fractures. However, resin monomers can be released 
into the oral environment and can trigger hazardous 
biological effects on oral tissues2. The release of the 
resin monomers due to degradation and incomplete 
polymerization can occur hours or days after the 
treatment7. Due to its hydrophilic nature, hydrolysis 
plays an important role in the degradation processes 
of TEGDMA24???????????????????????? ???????????????????
????????????????????? ??????????????????????????????
of resin monomers26. Direct contact or diffusion of 
resin monomers through the dentinal tubules creates 
ways of interaction between dental pulp tissue and 
resin monomers. Dentin thickness and the severity 
of caries lesions are important factors in determining 
the amount of resin monomers interacting with 
dental pulp tissue6,12. TEGDMA has been reported to 
cause cytotoxicity, impaired cellular functions, pulpal 
??????????????????????????????????????????? ?????
system2,6,14,19,27. In addition, TEGDMA may reduce 
the mineralization capacity of dental pulp cells by 
decreasing the expression of the mineralization related 
genes11??????????????????????????????????????????????
????? ??????? ?????? ??? ??????????? ?????????? ???????????
pathways and causing adverse effects.
Odontoclasts are key regulators controlling 
the eruption of deciduous teeth, and they show 
similar biological features to osteoclasts22,25. Besides, 
odontoclasts have important functions in pathological 
resorption of permanent teeth32. OPG/RANK/RANKL 
signaling pathway is known to play a key role in 
the differentiation of osteoclasts, which is strictly 
controlled by osteoblasts29. Osteoblasts/stromal cells 
express the receptor activator of nuclear factor (NF)-kB 
??????? ???????? ??? ????????? ??? ?????????? ???????????
dihydroxyvitamin D3? ??????????2D3), parathyroid 
hormone (PTH), IL-6, and IL-11. The activation of 
RANKL with the receptor activator of NF-kB (RANK), 
present on the surface of osteoclastic precursor 
cells, stimulates the osteoclastic differentiation from 
monocyte or macrophage progenitors. Osteoprotegerin 
(OPG) is a member of the tumor necrosis factor (TNF) 
receptor superfamily, which prevents RANK mediated 
activation of osteoclastic differentiation by binding to 
RANKL29.
Periodontal ligament fibroblasts are known to 
contribute to osteoclast formation and promote 
destructive inflammatory periodontal diseases28. 
Interactions with bacteria or mechanical loading play 
a key role during this process. Moreover, Uchiyama, et 
al.31 (2009) has shown that dental pulp and periodontal 
ligament cells support the differentiation and function 
of osteoclasts. Recently, Inamitsu, et al.16 (2017) 
reported that 2-hydroxyethyl methacrylate (HEMA) and 
TEGDMA inhibited the osteoclast differentiation through 
different signaling pathways in bone marrow-derived 
macrophages (BMMs) and murine monocytic cell line 
RAW-D. The role of periodontal ligament and pulp cells 
on osteoclastogenesis and the effects of different resin 
monomers on osteoclast formation have been shown 
in various studies. However, there are no studies so 
far on the odontoclastogenic activity of pulp cells in 
the presence of TEGDMA. The null hypothesis is that 
?????????????????????????????????????????????????????
differentiation ability of human dental pulp cells. 
Therefore, this study was carried out to determine if 
TEGDMA promotes the odontoclastic differentiation 
ability of human dental pulp cells (hDPCs). Thus, 
we evaluated the effects of TEGDMA on the ability 
of hDPCs to produce odontoclasts in the presence of 
CD14+ odontoclastic precursor cells derived from human 
peripheral blood.
Material and Methods
This study was conducted in full accordance with 
the World Medical Association Declaration of Helsinki 
and was approved by the Local Ethics Committee of 
the Gulhane Military Medical Academy (32/2014). All 
participants provided informed consent forms.
Cell culture
Dental pulp tissues were obtained from the molars of 
???????????????????????????????????????????????????????
The extracted molars were kept in phosphate-buffered 
saline solution (PBS, Biological Industries, Kibbutz Beit 
Haemek, Israel) containing 100 U/mL penicillin, and 
100 μg/mL streptomycin (Biological Industries, Kibbutz 
Beit Haemek, Israel). After they were transferred to the 
laboratory, the extracted molars were cut horizontally 
at 1 mm below the cementoenamel junction. The 
pulp tissues were gently separated from the crown 
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and root and placed in a 100-mm Petri dish. The pulp 
tissues were cut into small pieces with a sterile blade 
???? ????????? ??? ?????? ???????? ????? ??????????????
Grand Island, NY, USA) containing 10% fetal bovine 
serum (FBS; Biological Industries, Kibbutz Beit 
Haemek, Israel), 100 U/mL penicillin, and 100 μg/mL 
streptomycin (Biological Industries). Tissue cultures 
???????????????? ??? ?? ?????????? ??????????? ??? ???
CO2????????????????????????????????????????????????
for the experiments. 
Generation of CD14+ cells 
Histopaque–1077 (Sigma-Aldrich, St. Louis, 
MO, USA) was used to separate peripheral blood 
mononuclear cells (PBMC) from human peripheral 
blood by density-gradient centrifugation at 1800 rpm 
for 20 min. CD14+ cells were obtained from the PBMC 
with CD14 Microbeads (Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany) and SuperMACSTM II Separator 
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), 
in accordance with the manufacturer instructions.
Generation of odontoclasts and designation of 
study groups
The following study groups were designed to analyze 
odontoclastic differentiation:
Human dental pulp cells (hDPCs);
hDPCs + CD14+ cells; 
hDPCs + 1?,25(OH)2D3;
hDPCs + CD14+??????????????????2D3;
hDPCs + CD14+ cells + TEGDMA;
?????????????????2D3 + TEGDMA; and
hDPCs + CD14+??????????????????2D3, +TEGDMA.
Each experimental group consisted of nine samples. 
hDPCs were seeded into 6-well plates at a concentration 
???????4????????????????????????????????????????????????
Technologies, Grand Island, NY, USA) containing 10% 
FBS (Biological Industries, Kibbutz Beit Haemek, Israel), 
100 U/mL penicillin, and 100 μg/mL streptomycin 
(Biological Industries, Kibbutz Beit Haemek, Israel). 
??????????????? ????????????????????????????+ cells 
were used as odontoclast precursors and co-cultured 
????? ?????? ??? ????5 cells/well. The co-culture was 
performed in the presence or absence of 1?,25(OH)2D3 
(10–8 M) (Sigma-Aldrich, St. Louis, MO, USA) and 
TEGDMA (0.1, 0.3, 1, and 3 mM). The concentration 
??? ???? ?????????2D3 was chosen from a previously 
reported study21. Culture conditions were maintained 
??????????????????????????????????????????????2 at 
37°C, with medium change every 3 days.
Flow cytometry
Flow cytometry was used to evaluate odontoclastic 
differentiation after 14 days of incubation. After 
day 14, cells were suspended in 100 μL PBS, and 
stained with 10 μL anti-human CD51/CD61 mouse 
monoclonal antibody (BD Biosciences, USA), which 
bind selectively to odontoclasts, and incubated for 30 
min at room temperature. After incubation, samples 
were centrifuged at 300 g for 5 min. Pellets were re-
??????????????? ???? ??? ????? ???? ????????? ??? ????
cytometry (FACSDiva software, FACSAria, USA).
TRAP staining
??????????????????????????????????????????????????
solution (Sigma-Aldrich, St. Louis, MO, USA). After 
serial washing with PBS three times, odontoclasts 
were detected by staining for tartrate-resistant 
acid phosphatase (TRAP), a marker enzyme for 
odontoclasts, using a kit following the manufacturer’s 
recommendations (Cosmo Bio Co., Ltd., Tokyo, Japan). 
TRAP activity was observed under an optical microscope 
????????? ??????????????????????????????????? ??????????
Germany) and TRAP-positive cells were counted.
Apoptosis assay
?????? ?????????????????????????????????????5 cells/
well density and exposed to serial dilutions of TEGDMA 
(0.1, 0.3, 1, and 3 mM) for 24 h. Apoptosis in hDPCs was 
???????????????????????????????????????????????????
Staining Kit (Roche, Mannheim, Germany) following the 
manufacturer’s instructions. Each experimental group 
consisted of nine samples.
Quantitative Real-time PCR (qRT-PCR) analysis
?????? ?????????????????????????????????????6 cells/
??????????????????????????????????????????????????????
of 5% CO2 at 37°C (n=3 per experimental group). The 
cell cultures were exposed to serial dilutions of TEGDMA 
(0.1, 0.3, and 1 mM) for seven days. Total RNA was 
extracted from cultured hDPCs using an RNA isolation 
kit (High Pure RNA Isolation Kit, Roche, Mannheim, 
Germany), and cDNA was synthesized from 100 ng 
of total RNA using the Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche, Mannheim, Germany). The cDNA 
obtained was used as a template for PCR.
Human RANKL and OPG mRNA levels were analyzed 
to evaluate the effects of TEGDMA on odontoclastic 
differentiation capability of hDPCs. Glucose-6-
phosphate dehydrogenase (G6PD) was used as a 
housekeeping gene to normalize and determine 
?????????????????????????????????????????????????????????
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the relative expression levels of RANKL and OPG. 
Probe–primer pairs for target genes were purchased 
from Roche Diagnostic as RealTime ready assays, i.e. 
RANKL (Cat. no. 144633), OPG (Cat. no.142904), and 
G6PD (Cat. no.102098). Real-time PCR was performed 
using the FastStart Essential DNA Probes Master 
(Roche, Mannheim, Germany) and a LightCycler® 480 
Instrument II (Roche, Mannheim, Germany). Real-time 
PCR conditions were as follows: denaturation at 95°C 
for 10 min, followed by 45 cycles of 95°C for 10 s, 60°C 
for 30 s, 72°C for 1 s, and cooling at 40°C. The mRNA 
?????????????????????????????????????????????????????
method. Each experiment was performed in triplicate.
Enzyme-linked immunosorbent assay (ELISA)
?????? ?????????????????????????????????????6 cells/
??????????????????????????????????????????????????????
of 5% CO2 at 37°C (n=9 per experimental group). 
The cell cultures were exposed to serial dilutions of 
TEGDMA (0.1, 0.3, and 1 mM) for seven days. Protein 
concentrations of OPG and RANKL in the cell culture 
supernatant were analyzed by ELISA. The ELISA kits 
(MyBioSource Inc., San Diego, CA, USA) employed 
a sandwich ELISA technique containing a capture 
antibody and label antibody. All steps in the manuals 
were followed during the analysis and results were 
read on an ELISA plate reader (Reader ELx 800, Biokit, 
?????????????????????????????????????????????????????
????????????????????????????????????????????????????
they were stated as <15% for OPG in the kit manual).
Statistical analysis
The Kolmogorov-Smirnov test of distribution 
indicated that data for anti-CD51/CD61 positivity, 
TRAP positivity, apoptosis ratio, mRNA, and protein 
data for RANKL and OPG were skewed. Thus, results 
were summarized as medians and interquartile ranges. 
The Kruskal-Wallis test was used to compare three 
???????? ???????? ???? ?????? ??? ???????????? ??????????
was established at 0.05. SPSS Statistical Package 
Version 20.0 (IBM, Chicago, IL, USA) was used for all 
calculations.
Results
Analysis of odontoclastic differentiation
Odontoclastic differentiation ratios in the different 
groups were analyzed after 14 days of incubation 
????????????????????????????????????????????????????
CD14+ odontoclast precursor cells did not generate 
odontoclasts, as expected (data not shown). Co-culture 
of hDPCs and CD14+ cells (group ii) revealed the 
highest odontoclastic differentiation ratio. Addition of 
?????????2D3 decreased the odontoclastic differentiation 
ratio, particularly in hDPCs + CD14+ cells + 0.3 mM 
TEGDMA and hDPCs + CD14+ cells + 1 mM TEGDMA 
groups (p<0.05). No such changes were seen in hDPCs 
+ CD14+ and hDPCs + CD14+ cells + 0.1 mM TEGDMA 
groups (p>0.05). In general, the addition of TEGDMA 
lowered odontoclastic differentiation relative to groups 
without TEGDMA (p<0.05). Notably, 1 mM TEGDMA 
caused higher odontoclastic differentiation relative to 
0.1 and 0.3 mM TEGDMA (p<0.05). No cell viability/
odontoclastic differentiation was studied in the 3 mM 
TEGDMA group due to cytotoxicity (data not shown).
Odontoclast cell formation was confirmed by 
counting TRAP-positive cells, which phenotypically 
assessed odontoclastic differentiation (Figure 2). 
???? ???????? ????? ???? ?????????????? ?????? ??????????
???????????????? ????? ???? ?????????? ????????? ???????
1). However, 95±2% of TRAP-positive cells were 
mononuclear, and we did not detect any TRAP-positive 
cells in CD14+ negative groups.
Effect of TEGDMA on the apoptosis of dental 
pulp cells
hDPCs were exposed to 0.1, 0.3, 1, and 3 mM 
TEGDMA for 24 h, and it was found that TEGDMA 
dose-dependently induced apoptosis (Figure 3). 
Except for the lowest dose of 0.1 mM TEGDMA, the 
higher doses of 0.3, 1, and 3 mM TEGDMA increased 
apoptosis in comparison to the control group (p<0.001). 
Furthermore, there was a dose-dependent effect of 
TEDGMA on apoptosis induction in hDPCs.
Expression of RANKL and OPG mRNA in dental 
pulp cells
No differences were observed among the TEGDMA 
containing groups (0.1, 0.3, 1) in terms of RANKL mRNA 
levels after 7 days of incubation (p>0.05) (Figure 4a). 
However, OPG mRNA levels were lower in the TEGDMA 
containing groups relative to the control group, and 
TEGDMA treatments demonstrated a dose-dependent 
decrease (p<0.05) (Figure 4b). RANKL and OPG mRNA 
levels could not be detected in the 3 mM TEGDMA group 
due to cytotoxicity (data not shown).
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Figure 1-?????????????? ??????????????????????????????????? ???????????????????????????????????????????????????????????????????????
???????????? ?????????????????????? ?????????????????????????????????? ????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
+ 1?,25(OH)2D3 c) hDPCs + CD14 +0.1 mM TEGDMA d) hDPCs + CD14 +0.1 mM TEGDMA + 1?,25(OH)2D3 e) hDPCs + CD14 + 0.3 
mM TEGDMA f) hDPCs + CD14 + 0.3 mM TEGDMA + 1?,25(OH)2D3 g) hDPCs + CD14 + 1 mM TEGDMA h) hDPCs + CD14 + 1 mM ??????????????????2D3]
?????????????????????????????????????????????????????????
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RANKL and OPG protein levels in dental pulp 
cells
RANKL protein levels were higher in the TEGDMA 
treated hDPCs regarding the control group (p<0.05) 
(Figure 5a), and TEGDMA treatments demonstrated 
a dose-dependent increase. There was a statistically 
???????????????????????????????????????????????????????
and 3 mM TEGDMA containing groups (p<0.05).
OPG protein levels were lower in all TEGDMA treated 
groups regarding the control group (p<0.05) (Figure 
5b). In particular, the 0.1 mM TEGDMA group had 
relatively lower OPG protein levels compared to 0.3 
and 1 mM TEGDMA groups (p<0.05). There were no 
Study Groups (n=9) Median (Min-max) *(p<0.05)
1 hDPCs + CD14 2465 (1065-3100) 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8
2 hDPCs + CD14 + Vit D3 1043 (958-3742) 2-3, 2-4, 2-5, 2-6, 2-8
3 hDPCs + CD14 + 0.1 mM TEGDMA 260 (101-369) 3-6, 3-7, 3-8
4 hDPCs + CD14 + 0.1 mM TEGDMA + Vit D3 297 (98-456) 4-6, 4-7, 4-8
5 hDPCs + CD14 + 0.3 mM TEGDMA 276 (101-395) 5-6, 5-7, 5-8
6 hDPCs + CD14 + 0.3 mM TEGDMA + Vit D3 144 (108-165) 6-7, 6-8
7 hDPCs + CD14 + 1 mM TEGDMA 905 (760-1010) 7-8
8 hDPCs + CD14 + 1 mM TEGDMA + Vit D3 640 (586-750)
??????????????????????????????????????????????????????????????????????????????????????????????????
Table 1- Number of TRAP-positive cells generated by the co-colturing of human CD14+ cells and hDPCs in the presence or absence of 
Vit D3 and TEGDMA
Figure 2-?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
cells were observed through the co-culture of CD14+ cells and hDPCs at the end of 14 days incubation period. a) TRAP-negative b, c) 
TRAP-positive cells
Figure 3- Apoptosis in hDPCs was induced proportionally with the 
concentration of TEGDMA. Data are expressed as means±SD. 
????????????????????????????????????????????????????????????????
??????????????????????????????????
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Resin monomers cause adverse biological effects by 
modulating different regulatory cellular mechanisms. 
Previous studies have shown that TEGDMA can disrupt 
mineralization capacity leading to cytotoxicity in 
hDPCs1,6,11,18,20. Recently, it has been shown that dental 
pulp cells support the differentiation and function of 
odontoclasts31. However, the effect of TEGDMA on 
the ability of dental pulp cells to induce odontoclastic 
differentiation has not yet been determined. In this 
study, our aim was to evaluate the cellular processes 
related to odontoclastic differentiation in TEGDMA-
treated hDPCs. We anticipated that any information 
about the effects of TEGDMA on odontoclastic 
differentiation would provide a better understanding 
on the adverse effects of TEGDMA.
In this study, we attempted to determine the 
effects of TEGDMA on the generation of odontoclasts. 
This was carried out by co-culturing hDPCs and CD14+ 
monocytes derived from human peripheral blood. We 
conducted experiments in the presence or absence 
of 1?,25(OH)2D3, followed by incubating with serial 
?????????? ??? ???????????? ???????? ????????? ????? ????
cytometry analysis using anti-human CD51/CD61 
mouse monoclonal antibody was consistent with 
TRAP staining. However, TRAP-positive multinuclear 
cells constituted only 5±2% of all TRAP-positive 
cells. Previously, Domon, et al.10 (1997) reported that 
both mononuclear and multinucleated odontoclasts 
participate in tooth eruption, and further suggested 
that not all odontoclasts are multinucleated cells. 
Further, Hattersley & Chambers13 (1989) suggested that 
osteoclasts are initially mononuclear and might remain 
so, but later they become multinucleated. Moreover, 
odontoclastic cells can become multinucleated by 
cell fusion, and the formation of multinucleated 
odontoclasts has been described as an instantaneous 
event10. However, this study failed to observe a high 
proportion of multinuclear TRAP-positive cells and most 
of the odontoclasts were mononuclear. Although we do 
not have any evidence, we speculate that short culture 
time and higher biological activity of TEGDMA may 
have contributed to the high proportion of mononuclear 
TRAP-positive cells. Further, extending the culture 
period may increase the fusion of mononuclear cells.
The study groups without CD14+ cells did not reveal 
any odontoclastic differentiation. This observation 
was consistent with a previously reported study and 
reinforces the fact that odontoclastic precursor cells are 
required for odontoclastic differentiation31. Co-culture of 
hDPCs and CD14+ cells led to the highest odontoclastic 
differentiation ratio, and an addition of TEGDMA to the 
culture medium reduced odontoclastic differentiation 
ratios. Notably, the observed suppressive effect of 
TEGDMA was attenuated at higher concentrations. A 
reduction in the odontoclastic differentiation in the 
presence of lower doses of TEGDMA indicates that 
treatment with dental materials containing resin 
monomers may diminish the potential to induce 
odontoclastic resorption. However, a dose-dependent 
increase in the odontoclastic differentiation suggests 
that circumstances that lead to an increase in the 
release of resin monomers into oral environment, such 
Figure 4- Effects of TEGDMA on RANKL (a) and OPG (b) 
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as mechanical/chemical degradation or inadequate 
polymerization, may increase the possibility of 
odontoclastic resorption. Based on our observations, 
further studies are essential to explore the clinical 
effects of TEGDMA related odontoclastic differentiation.
It is known that 1?,25(OH)2D3 plays a key role in 
both odontoblastic and odontoclastic differentiation4. 
Normal levels of vitamin D and its active metabolite 
1?,25(OH)2D3 are important for bone mineralization. 
However, increased 1?,25(OH)2D3 enhances bone 
degradation by acting on osteoblasts, causing 
them to release RANKL, which in turn activates 
osteoclasts. Besides that, Kim, et al.17 (2013) 
reported that 1?,25(OH)2D3 inhibits the osteoclast 
differentiation by suppressing the expression of RANK 
in the human peripheral blood osteoclast precursors. 
Although methodologies and applied concentrations 
of 1?,25(OH)2D3 are different, this study is generally 
consistent with the aforementioned study17. This 
study revealed that generation of odontoclasts was 
????????????? ??????????? ??? ??,25(OH)2D3 in most of 
the study groups at a concentration of 10-8 M. This 
result indicates that 10-8 M of 1?,25(OH)2D3 causes a 
decrease in the odontoclastic differentiation ability of 
hDPCs, and may further suppress potentially adverse 
biologic effects of TEGDMA. On the contrary, Takahashi, 
et al.30 (2014) reported that 1?,25(OH)2D3 induces 
bone resorption and osteoclastogenesis by stimulating 
RANKL expression. We think that differences related 
to experimental design, cell types used, applied 
concentrations of 1?,25(OH)2D3, and differential 
biological activity of TEGDMA on dental pulp tissue may 
help explain the contradictory results. Even though we 
could not provide any evidence of a direct relationship 
between different 1?,25(OH)2D3 concentrations and 
quantity of odontoclastic differentiation, we speculate 
that dose changes in 1?,25(OH)2D3 may promote the 
odontoclastic differentiation ability of hDPCs based 
on previous reports. Therefore, further studies are 
necessary with different doses of 1?,25(OH)2D3 
Figure 5- Effects of TEGDMA on RANKL (a) and OPG (b) protein levels in TEGDMA treated hDPCs at the end of 7 days of incubation 
??????????????????????????????????????????????????????????????????????????????????????
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to evaluate the phenotypic effects of TEGDMA on 
odontoclastic differentiation.
RANKL plays an important role in bone regeneration 
and remodeling by activating osteoclasts/odontoclasts. 
Previous studies have shown that TEGDMA is a 
biologically active chemical and interacts with living 
?????? ??? ??????????? ?????????? ??????????? ????????8. 
Although TEGDMA did not affect the expression of 
RANKL mRNA, the RANKL protein was increased 
by TEGDMA in hDPCs. Therefore, TEGDMA may be 
affecting post-transcriptional regulation of gene 
expression. Notably, RANKL seems to be an important 
regulatory factor in odontoclastic differentiation of 
TEGDMA treated hDPCs. OPG is known as the main 
inhibitor of the osteoclastic/odontoclastic differentiation 
process. Our results indicate that TEGDMA decreased 
the expression of OPG mRNA and protein in a dose-
dependent manner. This effect was consistent with our 
????????????????????????????????????????????????????
indicated an increase in odontoclastic differentiation 
with an increased dose of TEGDMA. However, when 
all results were taken into account, there seems to 
be a discrepancy between them. Increase of RANKL 
and decrease of OPG proteins are supposed to induce 
odontoclastic differentiation. However, the number 
of anti-human CD51/CD61 and TRAP positive cells 
were decreased by TEGDMA treatment, compared 
to control, as shown in Figure 1 and Table 1. In this 
study, we examined the effects of TEGDMA on the 
RANKL and OPG proteins, which were upstream of the 
odontoclastic differentiation pathway,. However, there 
are several downstream signaling pathways related 
???????????????????????????????????????????????????????
Akt, ERK, JNK, and p38 MAPKs5,9,23,33. Additional effects 
of TEGDMA on these different signaling pathways may 
contribute to the effects of TEGDMA on the odontoclastic 
differentiation ability of hDPCs and may be the cause 
of this inconsistency between the results.
Recently, Inamitsu, et al.16 (2017) reported that HEMA 
and TEGDMA inhibited the osteoclast differentiation in 
BMMs and RAW-D cells. Furthermore, the study also 
showed that NFATc1, ERK, and JNK signaling pathways 
played a key role in osteoclastogenesis for the HEMA, 
whereas NFATc1, Akt, and JNK pathways associated 
with the TEGDMA mediated osteoclastogenesis. The 
results seem similar in some aspects and support 
?????????????????????? ?????????????????????????????
between the two studies. Unlike this study, Inamitsu, 
et al.16 (2017) reported a decrease in the osteoclastic 
differentiation of BMMs with the increasing dose of 
TEGDMA in TRAP analysis. However, odontoclastic 
differentiation ratios revealed an augmentation with 
increasing dose of TEGDMA in this study. Differences 
between the experimental designs may be the cause 
?????????????????????????????????????????????????????16 
(2017) counted only the cells with three or more nuclei 
as TRAP-positive, whereas we took into account all the 
mononuclear and multinucleated cells during the TRAP 
analysis. Cell types and duration of the culture time 
used to monitoring osteoclastic differentiation were also 
different and this phenomenon may be an important 
factor for the osteoclastic differentiation of the cells. 
Furthermore, Inamitsu, et al.16 (2017) showed that 
TEGDMA has slight cytotoxic effects on BMM-derived 
osteoclasts. When we examined the results of the study, 
cytotoxicity was found to be mild at doses up to 1 mM, 
but cytotoxicity gradually increased at doses between 
1 and 2 mM. Moreover, Inamitsu, et al.16 (2017) did not 
test the more cytotoxic doses of TEGDMA such as 3 mM 
as this study. It is to be noted that in the presence of a 
high dose of TEGDMA (3 mM) no results were obtained 
???????????????????????????????????????????????????
analyses. Consistent with previous studies indicating 
that TEGDMA can activate apoptotic pathways3,15, this 
study revealed that TEGDMA caused a dose-dependent 
increase in apoptosis of hDPCs and cell viability has 
been adversely affected in the presence of high doses 
of TEGDMA. Therefore, it has not been possible to carry 
out studies on the effects of high doses of TEGDMA on 
odontoclastic differentiation ability of hDPCs.
Resin composites are widely used in dentistry and 
many factors such as secondary caries, defects in 
restorations, marginal degradation, and pulpal death 
may cause the replacement of restorations or fail of the 
treatment. A detailed understanding of biological effects 
of resin monomers is important to increase treatment 
???????????????????????????????????????????????????????
or loss of the tooth. Therefore, the inhibitory effects 
of resin monomers on odontoclastic differentiation 
ability of hDPCs may help understand the effects of 
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Conclusion
We found that TEGDMA reduces the odontoclastic 
differentiation ability of hDPCs. However, odontoclastic 
differentiation ratios augmented with increasing dose 
of TEGDMA.
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